IceCure Medical Ltd.(ICCM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ICCM IceCure Medical Ltd.

Trading 11-05 14:34:18 EST

0.8075

-0.0425

-5.00%

High0.8607	Low0.7950	Vol241.35K
Open0.8600	D1 Closing0.8500	Amplitude7.73%
Mkt Cap44.82M	Tradable Cap23.16M	Total Shares55.50M
T/O198.30K	T/O Rate0.84%	Tradable Shares28.68M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ICCM","market":"US","secType":"STK","nameCN":"IceCure Medical Ltd.","latestPrice":0.8075,"timestamp":1730835105882,"preClose":0.85,"halted":0,"volume":241348,"delay":0,"floatShares":28675700,"shares":55501599,"eps":-0.292716,"marketStatus":"Trading","change":-0.0425,"latestTime":"11-05 14:34:18 EST","open":0.86,"high":0.8607,"low":0.795,"amount":198304.2358396,"amplitude":0.077294,"askPrice":0.815,"askSize":800,"bidPrice":0.8,"bidSize":5100,"shortable":3,"etf":0,"ttmEps":-0.292716,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1730840400000},"marketStatusCode":2,"adr":0,"listingDate":1629950400000,"exchange":"NASDAQ","adjPreClose":0.85,"preHourTrading":{"tag":"盘前","latestPrice":0.8607,"preClose":0.85,"latestTime":"09:09 EST","volume":3267,"amount":2809.9803501,"timestamp":1730815741001},"postHourTrading":{"tag":"盘后","latestPrice":0.8608,"preClose":0.85,"latestTime":"19:46 EST","volume":7906,"amount":6785.347,"timestamp":1730767587861},"volumeRatio":0.253759},"requestUrl":"/m/hq/s/ICCM/tweets","defaultTab":"tweets","newsList":[{"id":"2479540468","title":"Upcoming FDA Advisory Panel for IceCure's ProSense® Marketing Authorization Receives Large Number of Public Comments from Stakeholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2479540468","media":"PR Newswire","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479540468?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:30","pubTimestamp":1730205000,"startTime":"0","endTime":"0","summary":"Comments from key stakeholders, including doctors, nurses, researchers, and breast cancer patients, are available on FDA website. FDA Advisory Panel providing recommendations and vote on information concerning the benefit-risk profile for a De Novo marketing submission of the IceCure ProSense Cryoablation System in early-stage low risk breast cancer scheduled for November 7, 2024. \"We are highly encouraged by the large number of comments received for the Advisory Panel's consideration regarding the role of ProSense as a minimally-invasive treatment option for early-stage low risk breast cancer patients. Key stakeholders, including breast cancer patients, have shared their first-hand experience with ProSense,\" stated IceCure's CEO, Eyal Shamir. \"We look forward to the public forum on November7, along with the Advisory Panel's vote, which the FDA will consider in making its decision, expected by early 2025.\". The ProSense Cryoablation System provides a minimally invasive treatment option","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gLojd3jfLjCdwgJQFQQ3kg--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf48d042cc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gLojd3jfLjCdwgJQFQQ3kg--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf48d042cc"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/upcoming-fda-advisory-panel-icecures-123000025.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/upcoming-fda-advisory-panel-icecures-123000025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Upcoming FDA Advisory Panel for IceCure's ProSense® Marketing Authorization Receives Large Number of Public Comments from Stakeholders","news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ICCM","BK4082"],"gpt_icon":1},{"id":"2477454867","title":"BRIEF-Icecure Receives Notice Of Allowance From U.S. Patent And Trademark Office For Its Next-Generation Cryoablation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2477454867","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477454867?lang=en_us&edition=fundamental","pubTime":"2024-10-21 23:32","pubTimestamp":1729524726,"startTime":"0","endTime":"0","summary":"Oct 21 (Reuters) - Icecure Medical Ltd   :   * ICECURE RECEIVES NOTICE OF ALLOWANCE FROM U.S. PATENT AND TRADEMARK OFFICE FOR ITS NEXT-GENERATION CRYOABLATION SYSTEMSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICCM","BK4082"],"gpt_icon":0},{"id":"2477857045","title":"IceCure Medical Expands Patent Portfolio with New US Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2477857045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477857045?lang=en_us&edition=fundamental","pubTime":"2024-10-21 20:55","pubTimestamp":1729515320,"startTime":"0","endTime":"0","summary":"Icecure Medical (ICCM) has released an update. IceCure Medical has received a Notice of Allowance from the U.S. Patent and Trademark Office for its...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecure-medical-expands-patent-portfolio-with-new-us-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecure-medical-expands-patent-portfolio-with-new-us-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICCM","BK4082"],"gpt_icon":0},{"id":"2477522828","title":"IceCure Medical granted patent by USPTO for cryoablation system","url":"https://stock-news.laohu8.com/highlight/detail?id=2477522828","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477522828?lang=en_us&edition=fundamental","pubTime":"2024-10-21 20:35","pubTimestamp":1729514154,"startTime":"0","endTime":"0","summary":"IceCure Medical (ICCM) has received a Notice of Allowance for its invention titled “Cryogenic System Connector” from the USPTO. This is the first g...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/icecure-medical-granted-patent-by-uspto-for-cryoablation-system?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/icecure-medical-granted-patent-by-uspto-for-cryoablation-system?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICCM","BK4082"],"gpt_icon":0},{"id":"2477852538","title":"Icecure Receives Notice of Allowance From U.S. Patent and Trademark Office for Its Next-Generation Cryoablation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2477852538","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477852538?lang=en_us&edition=fundamental","pubTime":"2024-10-21 20:33","pubTimestamp":1729513984,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241021:nFWN3LX0NL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ICCM","BK4082"],"gpt_icon":0},{"id":"2477918857","title":"IceCure Receives Notice of Allowance from U.S. Patent and Trademark Office for its Next-Generation Cryoablation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2477918857","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477918857?lang=en_us&edition=fundamental","pubTime":"2024-10-21 20:30","pubTimestamp":1729513800,"startTime":"0","endTime":"0","summary":"Innovative cryogenic system connector technology designed to improve usability and maintain the integrity of cryogen used in the cryoablation procedure. CAESAREA, Israel, Oct. 21, 2024 /PRNewswire/ --IceCure Medical Ltd.  , developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced it has received a Notice of Allowance for its invention titled \"Cryogenic System Connector\" from the U.S. Patent and Trademark Office. This is the first global patent issued for the cryogenic system connector, a key component of IceCure's next-generation liquid nitrogen-based XSense cryoablation system. Several other patent applications for this technology are pending in key markets.XSense and its cryoprobes, which have U.S. Food and Drug Administration clearance for all of the indications for which IceCure's flagship ProSense has already received clearance, has the potential to address additional indications and signi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gLojd3jfLjCdwgJQFQQ3kg--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf48d042cc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gLojd3jfLjCdwgJQFQQ3kg--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf48d042cc"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/icecure-receives-notice-allowance-u-123000991.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icecure-receives-notice-allowance-u-123000991.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","ICCM"],"gpt_icon":0},{"id":"2475696955","title":"IceCure Medical files to sell ordinary shares and warrants, no amount given","url":"https://stock-news.laohu8.com/highlight/detail?id=2475696955","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475696955?lang=en_us&edition=fundamental","pubTime":"2024-10-16 04:30","pubTimestamp":1729024214,"startTime":"0","endTime":"0","summary":"The company engaged Maxim Group as its lead placement agent and Roth Capital Partners as a co-placement agent to use their best efforts to solicit ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/icecure-medical-files-to-sell-ordinary-shares-and-warrants-no-amount-given?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/icecure-medical-files-to-sell-ordinary-shares-and-warrants-no-amount-given?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICCM","BK4082"],"gpt_icon":0},{"id":"2475828031","title":"Icecure Medical: A Strong Buy on Clinical Success and Upcoming Regulatory Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2475828031","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475828031?lang=en_us&edition=fundamental","pubTime":"2024-10-14 00:05","pubTimestamp":1728835514,"startTime":"0","endTime":"0","summary":"Analyst Anthony Vendetti from Maxim Group reiterated a Buy rating on Icecure Medical (ICCM – Research Report) and keeping the price target at $3.00...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/icecure-medical-a-strong-buy-on-clinical-success-and-upcoming-regulatory-catalysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/icecure-medical-a-strong-buy-on-clinical-success-and-upcoming-regulatory-catalysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","ICCM"],"gpt_icon":0},{"id":"2474263777","title":"Alignment HealthCare Partners With Intermountain Health in Nevada","url":"https://stock-news.laohu8.com/highlight/detail?id=2474263777","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474263777?lang=en_us&edition=fundamental","pubTime":"2024-10-10 22:10","pubTimestamp":1728569400,"startTime":"0","endTime":"0","summary":"Alignment HealthCare, Inc.’s ALHC leading Medicare Advantage plan, Alignment Health Plan, is expanding its healthcare services in Nevada through a new agreement with Intermountain Health. Beginning Jan. 1, 2025, the partnership will give Medicare members in Clark and Washoe counties access to over 65 clinic locations, including 35 award-winning senior primary care clinics. This collaboration promises to enhance the level of care available to Nevada’s growing senior population.Alignment HealthCare, known for its mission-driven approach to providing high-quality, affordable care for Medicare Advantage members, collaborates with trusted providers to deliver coordinated, personalized care. Intermountain Health, a nonprofit system with 33 hospitals and 385 clinics across six states, is recognized for its leadership in transforming healthcare through evidence-based practices and community health initiatives. This partnership aims to provide expanded healthcare services to Nevada's senior pop","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ZcqDt7bCeBMLkGs_KJ1O8A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/228e67967b066e7a755ae3614be720e1","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ZcqDt7bCeBMLkGs_KJ1O8A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/228e67967b066e7a755ae3614be720e1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alignment-healthcare-partners-intermountain-health-141000515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065731478.USD","LU1169590202.USD","BK4082","BK4539","BK4568","ALHC","ICCM","HQY","CODX","BK4154","LU1169589451.USD"],"gpt_icon":0},{"id":"2473810860","title":"IceCure’s ProSense Excels in Global Cryoablation Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2473810860","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473810860?lang=en_us&edition=fundamental","pubTime":"2024-10-07 20:57","pubTimestamp":1728305855,"startTime":"0","endTime":"0","summary":"Icecure Medical (ICCM) has released an update. IceCure Medical’s ProSense system showcased impressive results at the European Society of Breast Ima...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecures-prosense-excels-in-global-cryoablation-studies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecures-prosense-excels-in-global-cryoablation-studies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","ICCM"],"gpt_icon":0},{"id":"2473177101","title":"IceCure's ProSense® Featured in 6 Global Studies on Cryoablation of Breast Tumors at the 2024 European Society of Breast Imaging Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2473177101","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473177101?lang=en_us&edition=fundamental","pubTime":"2024-10-07 20:15","pubTimestamp":1728303300,"startTime":"0","endTime":"0","summary":"ICE3 trial results presentation by Co-Principal Investigator Dr. Kenneth Tomkovich wins EUSOBI 2024 Abstract Award. THERMAC Trial on Treatment of Breast Cancer with Percutaneous Thermal Ablation  wins EUSOBI Young Physician Scientist Competition – cryoablation demonstrates 94% complete rate of ablation. IceCure exhibited ProSense and conducted hands-on demos and Q&A sessions with breast cryoablation experts Dr. Lucía Graa-López and Dr. Federica Di Naro. An estimated 1700+ professionals in attendance at EUSOBI had the opportunity to learn more about the ProSense Cryoablation System for the treatment of fibroadenoma and breast cancer, both of which are approved indications for ProSense in Europe. IceCure's booth featured live demonstrations from expert users and the IceCure team, who were on hand to discuss the growing evidence for breast cancer cryoablation and ProSense's advantages. On October 4, world-leading cryoablation exp","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gLojd3jfLjCdwgJQFQQ3kg--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf48d042cc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gLojd3jfLjCdwgJQFQQ3kg--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf48d042cc"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/icecures-prosense-featured-6-global-121500737.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icecures-prosense-featured-6-global-121500737.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4190","BK4082","BC","ICCM"],"gpt_icon":0},{"id":"2472696618","title":"Zacks.com featured highlights Adverum Biotechnologies, IceCure, DarioHealth, Energous and Virgin Galactic","url":"https://stock-news.laohu8.com/highlight/detail?id=2472696618","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472696618?lang=en_us&edition=fundamental","pubTime":"2024-10-03 17:17","pubTimestamp":1727947020,"startTime":"0","endTime":"0","summary":"Chicago, IL – October 3, 2024 – Stocks in this week’s article are Adverum Biotechnologies ADVM, IceCure Medical ICCM, DarioHealth DRIO, Energous WATT and Virgin Galactic SPCE.Investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio. This strategy is based on the notion that the lower the P/E ratio, the higher the stock value. The reasoning behind this is straightforward — when a stock's current market price does not adequately reflect its higher earnings, it suggests potential for growth.But there is more to this whole P/E story. Because not only low P/E, stocks with a rising P/E can also fetch strong returns. In this regard, investors can bet on the likes of Adverum Biotechnologies, IceCure Medical, DarioHealth, Energous and Virgin Galactic.The concept is that as earnings rise, so should the price of the stock. As forecasts for expected earnings come in higher, strong demand for the stock should continue to push up its prices. Af","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/m4zD4jXaI337RECPySpJiA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e304e5f17ad14d4183a4085174bd37f0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/m4zD4jXaI337RECPySpJiA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e304e5f17ad14d4183a4085174bd37f0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-com-featured-highlights-adverum-091700896.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","DRIO","BK4562","SPCE","WATT","BK4139","ICCM","BK4187","ADVM","BK4167","BK4564","BK4096"],"gpt_icon":0},{"id":"2472517755","title":"Bet on 5 Top-Ranked Stocks With Rising P/E","url":"https://stock-news.laohu8.com/highlight/detail?id=2472517755","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472517755?lang=en_us&edition=fundamental","pubTime":"2024-10-02 16:29","pubTimestamp":1727857740,"startTime":"0","endTime":"0","summary":"Investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio. This strategy is based on the notion that the lower the P/E ratio, the higher the stock value. The reasoning behind this is straightforward — when a stock's current market price does not adequately reflect its higher earnings, it suggests potential for growth.But there is more to this whole P/E story. Because not only low P/E, stocks with a rising P/E can also fetch strong returns. In this regard, investors can bet on the likes of Adverum Biotechnologies ADVM, IceCure Medical ICCM, DarioHealth DRIO, Energous WATT and Virgin Galactic SPCE.The concept isthat as earnings rise, so should the price of the stock. As forecasts for expected earnings come in higher, strong demand for the stock should continue to push up its prices. After all, astock's P/E gives an indication of how much investors are ready to shell out per dollar of earnings.Percentage price change for four weeks re","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/sY66oHaDxjlcbPOCsEmN3w--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1f78a8639489577f3b2f81e40a790d91","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/sY66oHaDxjlcbPOCsEmN3w--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1f78a8639489577f3b2f81e40a790d91"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bet-5-top-ranked-stocks-082900521.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4187","BK4167","UPRO","DRIO","BK4562","OEF","ESmain","BK4559",".SPX","VOO","ADVM","SDS","BK4082","SPY","IVV","OEX","SSO","SPXU","BK4550","BK4581","SH","BK4504","SPCE","BK4139","BK4096","ICCM","BK4588","BK4585","BK4564","WATT","BK4534"],"gpt_icon":0},{"id":"2469496586","title":"IceCure Medical’s ProSense® Shows Promising Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2469496586","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469496586?lang=en_us&edition=fundamental","pubTime":"2024-09-24 20:57","pubTimestamp":1727182648,"startTime":"0","endTime":"0","summary":"Icecure Medical (ICCM) has released an update. IceCure Medical’s ProSense® Cryoablation system has demonstrated a 96.3% recurrence-free rate in ear...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecure-medicals-prosense-shows-promising-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecure-medicals-prosense-shows-promising-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICCM","BK4082"],"gpt_icon":0},{"id":"2469296493","title":"IceCure's ICE3 5-Year Trial Results Published in the Peer Reviewed Annals of Surgical Oncology Journal: ProSense® Cryoablation Without Excision for Early-Stage, Low-Risk Breast Cancer Demonstrates 96.3% Recurrence Free Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2469296493","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469296493?lang=en_us&edition=fundamental","pubTime":"2024-09-24 20:15","pubTimestamp":1727180100,"startTime":"0","endTime":"0","summary":"Publication comes ahead of the FDA Advisory Panel Meeting for Marketing Authorization of ProSense in Early-Stage Low Risk Breast Cancer scheduled for November 7, 2024. Lead study author, Dr. Richard E. Fine, is an ICE3 investigator and winner of the 2024 American Society of Breast Surgeons' Scientific Impact Award for his presentation of the ICE3 trial data.Dr. Fine commented, \"Our analysis of the trial's primary outcome, ipsilateral breast tumor recurrence  at 5 years, suggests that cryoablation with ProSense is safe and effective for patients with early-stage low-risk breast cancer. At the 5-year f","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gLojd3jfLjCdwgJQFQQ3kg--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf48d042cc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gLojd3jfLjCdwgJQFQQ3kg--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf48d042cc"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/icecures-ice3-5-trial-results-121500989.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icecures-ice3-5-trial-results-121500989.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ICCM","SSI","BK4082"],"gpt_icon":0},{"id":"2467103458","title":"IceCure’s ProSense Shows High Success in Tumor Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2467103458","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467103458?lang=en_us&edition=fundamental","pubTime":"2024-09-16 20:51","pubTimestamp":1726491107,"startTime":"0","endTime":"0","summary":"Icecure Medical (ICCM) has released an update. IceCure Medical’s ProSense cryoablation technology, which destroys tumors by freezing, demonstrated ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecures-prosense-shows-high-success-in-tumor-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecures-prosense-shows-high-success-in-tumor-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","ICCM"],"gpt_icon":0},{"id":"2467081466","title":"Study Published in the British Journal of Radiology Demonstrates IceCure's ProSense® is a Safe Procedure with 97.7% Technical Success Rate in Treating Tumors of the Lung, Bone, and Soft Tissues","url":"https://stock-news.laohu8.com/highlight/detail?id=2467081466","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467081466?lang=en_us&edition=fundamental","pubTime":"2024-09-16 20:00","pubTimestamp":1726488000,"startTime":"0","endTime":"0","summary":"Liquid nitrogen-  based ProSense found to have favorable safety compared to argon-based cryoablation systems, as well as being more cost effective and easier to manage. Independent study conducted at the European Institute of Oncology  demonstrates interventional radiology use cases for ProSense for indications that are approved in various markets across the world. LN2-based cryoablation was compared to argon-based systems in the study who point to the benefits of LN2 procedures including its suitability for office-based procedures performed under local anesthesia, compared to argon systems which typically require general anesthesia and are therefore less suitable for office procedures. The study also addresses the challenges of argon systems requiring large argon gas cylinders, which necessitate dedicated storage space and trained","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gLojd3jfLjCdwgJQFQQ3kg--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf48d042cc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gLojd3jfLjCdwgJQFQQ3kg--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf48d042cc"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/study-published-british-journal-radiology-120000504.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/study-published-british-journal-radiology-120000504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ICCM","IEO","BK4082"],"gpt_icon":0},{"id":"2467842587","title":"Icecure Medical Price Target Maintained With a $2.50/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2467842587","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467842587?lang=en_us&edition=fundamental","pubTime":"2024-09-13 02:10","pubTimestamp":1726164600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ICCM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 12, 2024 14:10 ET (18:10 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ICCM"],"gpt_icon":0},{"id":"2467628783","title":"IceCure Medical’s ProSense Positioned for Market Success Following FDA Panel Meeting, Analyst Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2467628783","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467628783?lang=en_us&edition=fundamental","pubTime":"2024-09-13 00:15","pubTimestamp":1726157716,"startTime":"0","endTime":"0","summary":"Icecure Medical (ICCM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yi Chen from H.C. Wa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/icecure-medicals-prosense-positioned-for-market-success-following-fda-panel-meeting-analyst-maintains-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/icecure-medicals-prosense-positioned-for-market-success-following-fda-panel-meeting-analyst-maintains-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICCM"],"gpt_icon":0},{"id":"2467783515","title":"FDA AdComm to discuss IceCure's ProSense on Nov. 7","url":"https://stock-news.laohu8.com/highlight/detail?id=2467783515","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467783515?lang=en_us&edition=fundamental","pubTime":"2024-09-12 23:27","pubTimestamp":1726154871,"startTime":"0","endTime":"0","summary":"IceCure Medical  said an FDA advisory committee will meet on Nov. 7 to discuss its De Novo Classification Request for market authorization of its ProSense cryoablation device. The Israeli company is seeking to have the product authorized for the treatment of early-stage low-risk invasive breast cancer with cryoablation and adjuvant endocrine therapy.  IceCure  said it expects the FDA to issue a decision on the marketing authorization by early 2025, according to a statement.","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1387472103/image_1387472103.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1387472103/image_1387472103.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4149143-fda-adcomm-to-discuss-icecures-prosense-on-nov-7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["ICCM","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.icecure-medical.com","stockEarnings":[{"period":"1week","weight":0.2879},{"period":"1month","weight":0.4001},{"period":"3month","weight":0.3821},{"period":"6month","weight":-0.2735},{"period":"1year","weight":0.1183},{"period":"ytd","weight":-0.2056}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.034786},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.052093},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.02219},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.004073},{"month":5,"riseRate":0,"avgChangeRate":-0.132422},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.098239},{"month":7,"riseRate":0.666667,"avgChangeRate":0.014625},{"month":8,"riseRate":0,"avgChangeRate":-0.095675},{"month":9,"riseRate":0,"avgChangeRate":-0.232692},{"month":10,"riseRate":0.5,"avgChangeRate":0.131383},{"month":11,"riseRate":0.5,"avgChangeRate":-0.018841},{"month":12,"riseRate":0.333333,"avgChangeRate":0.053535}],"exchange":"NASDAQ","name":"IceCure Medical Ltd.","nameEN":"IceCure Medical Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IceCure Medical Ltd.(ICCM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest IceCure Medical Ltd.(ICCM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"IceCure Medical Ltd.,ICCM,IceCure Medical Ltd.股票,IceCure Medical Ltd.股票老虎,IceCure Medical Ltd.股票老虎国际,IceCure Medical Ltd.行情,IceCure Medical Ltd.股票行情,IceCure Medical Ltd.股价,IceCure Medical Ltd.股市,IceCure Medical Ltd.股票价格,IceCure Medical Ltd.股票交易,IceCure Medical Ltd.股票购买,IceCure Medical Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IceCure Medical Ltd.(ICCM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest IceCure Medical Ltd.(ICCM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction